Statements (33)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:drug
histamine analog |
gptkbp:approvedBy |
gptkb:Australia
gptkb:Canada gptkb:Europe |
gptkbp:ATCCode |
N07CA01
|
gptkbp:CASNumber |
5638-76-6
|
gptkbp:chemicalClass |
alkylamine
|
gptkbp:compatibleWith |
gptkb:United_States
|
gptkbp:contraindication |
gptkb:pheochromocytoma
active peptic ulcer |
gptkbp:discoveredBy |
gptkb:UCB_Pharma
|
gptkbp:eliminationHalfLife |
3-4 hours
|
gptkbp:excretion |
renal
|
gptkbp:hasMolecularFormula |
C8H12N2
|
https://www.w3.org/2000/01/rdf-schema#label |
betahistine
|
gptkbp:introducedIn |
1968
|
gptkbp:legalStatus |
prescription only
|
gptkbp:mechanismOfAction |
histamine H1 receptor agonist
histamine H3 receptor antagonist |
gptkbp:metabolism |
hepatic
|
gptkbp:pregnancyCategory |
gptkb:C_(Australia)
|
gptkbp:routeOfAdministration |
oral
|
gptkbp:sideEffect |
nausea
headache gastric upset |
gptkbp:synonym |
Serc
Betaserc |
gptkbp:UNII |
8E5I2K1KAT
|
gptkbp:usedFor |
gptkb:Ménière's_disease
vertigo |
gptkbp:bfsParent |
gptkb:H3_receptor
|
gptkbp:bfsLayer |
7
|